• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Shifting from targeted therapies to personalised treatment in chordoma.

作者信息

D'Alessandris Quintino Giorgio, Della Pepa Giuseppe Maria, Offi Martina, Pallini Roberto, Olivi Alessandro

机构信息

Department of Neurosurgery, Fondazione Policlinico Universitario "A Gemelli" IRCCS, Universitá Cattolica del Sacro Cuore, Rome 00168, Italy.

Department of Neurosurgery, Fondazione Policlinico Universitario "A Gemelli" IRCCS, Universitá Cattolica del Sacro Cuore, Rome 00168, Italy.

出版信息

Lancet Oncol. 2020 Dec;21(12):e547. doi: 10.1016/S1470-2045(20)30684-7.

DOI:10.1016/S1470-2045(20)30684-7
PMID:33271104
Abstract
摘要

相似文献

1
Shifting from targeted therapies to personalised treatment in chordoma.脊索瘤治疗从靶向治疗向个性化治疗的转变
Lancet Oncol. 2020 Dec;21(12):e547. doi: 10.1016/S1470-2045(20)30684-7.
2
Shifting from targeted therapies to personalised treatment in chordoma - Authors' reply.
Lancet Oncol. 2020 Dec;21(12):e548. doi: 10.1016/S1470-2045(20)30696-3.
3
Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.新型脊索瘤细胞系统的临床前特征及其细胞周期通路 CDK4/6 药理学抑制剂的靶向治疗。
Cancer Res. 2015 Sep 15;75(18):3823-31. doi: 10.1158/0008-5472.CAN-14-3270. Epub 2015 Jul 16.
4
The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.下一步：创新的分子靶向治疗方法治疗颅内脊索瘤患者。
Neurosurgery. 2011 Jan;68(1):231-40; discussion 240-1. doi: 10.1227/NEU.0b013e3181fd2ac5.
5
[Personalised medicine. Paradigm shift within drug research and therapy].[个性化医疗。药物研究与治疗领域的范式转变]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1495-501. doi: 10.1007/s00103-013-1820-4.
6
Chordoma: a case series and review of the literature.脊索瘤：病例系列及文献综述
J Med Case Rep. 2018 Aug 27;12(1):239. doi: 10.1186/s13256-018-1784-y.
7
Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.晚期或转移性脊索瘤患者的分子靶向治疗：事实与假说
Crit Rev Oncol Hematol. 2015 Jul;95(1):125-31. doi: 10.1016/j.critrevonc.2015.01.010. Epub 2015 Jan 30.
8
Personalized/Precision Medicine/Personalised Healthcare: the art of giving different names to the same thing?个性化医疗/精准医疗/个人化医疗保健：给同一事物取不同名字的艺术？
Per Med. 2017 Nov;14(6):463-466. doi: 10.2217/pme-2017-0073. Epub 2017 Oct 26.
9
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).一线分子靶向治疗晚期脊索瘤：疗效与预后因素。法国肉瘤研究组（GSF/GETO）和法国神经肿瘤学家协会（ANOCEF）的一项回顾性研究。
Eur J Cancer. 2017 Jul;79:119-128. doi: 10.1016/j.ejca.2017.03.037. Epub 2017 May 4.
10
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.PI3K/mTOR抑制联合疗法在人类脊索瘤中显示出疗效。
Anticancer Res. 2009 Jun;29(6):1867-71.

引用本文的文献

1
Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review.斜坡脊索瘤的治疗：20年经验及系统文献综述
Cancers (Basel). 2023 Sep 9;15(18):4493. doi: 10.3390/cancers15184493.